Cargando…

Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials

BACKGROUND: Severe pneumonia (SP) has a high mortality and is responsible for significant healthcare cost. Chinese herbal injections (CHIs) have been widely used in China as a novel and promising treatment option for SP. Therefore, this study will assess and rank the effectiveness of CHIs to provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Lu, Niu, Liqing, Zhang, Xuemin, Liu, Xuezheng, Liu, Xinqiao, Sun, Chongxiang, Yang, Xiaokun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126378/
https://www.ncbi.nlm.nih.gov/pubmed/35604894
http://dx.doi.org/10.1371/journal.pone.0262776
_version_ 1784712115481739264
author Xiao, Lu
Niu, Liqing
Zhang, Xuemin
Liu, Xuezheng
Liu, Xinqiao
Sun, Chongxiang
Yang, Xiaokun
author_facet Xiao, Lu
Niu, Liqing
Zhang, Xuemin
Liu, Xuezheng
Liu, Xinqiao
Sun, Chongxiang
Yang, Xiaokun
author_sort Xiao, Lu
collection PubMed
description BACKGROUND: Severe pneumonia (SP) has a high mortality and is responsible for significant healthcare cost. Chinese herbal injections (CHIs) have been widely used in China as a novel and promising treatment option for SP. Therefore, this study will assess and rank the effectiveness of CHIs to provide more sights for the selection of SP treatment. METHOD: Seven databases will be searched, including PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Database, and the Chinese Scientific Journal Database (VIP) from their inception up to October, 2021. The literatures screening, data extraction and the quality assessment of included studies will be conducted independently by two reviewers. Then Bayesian network meta-analysis (NMA) will be performed by WinBUGS 14.0 and STATA 14.0 software. Surface under the cumulative ranking curve (SUCRA) probability values will be applied to rank the examined treatments. The risk of bias of each included study will be evaluated using the Revised Cochrane risk-of-bias tool for randomized trials (ROB 2). Publication bias will be reflected by a funnel plot. RESULTS: The results of this NMA will be disseminated through a peer-reviewed journal publication. CONCLUSION: Our study findings maybe reveal which CHI or CHIs will be better in the treatment of SP and provide more therapy strategies for clinical practitioners and patients. PROSPERO REGISTRATION NUMBER: CRD42021244587. STRENGTHS AND LIMITATIONS OF THIS STUDY: Bayesian network meta-analysis (NMA) can integrate direct evidence with indirect evidence of severe pneumonia treated by Chinese herbal injections to generate a clinically useful ranking of these regimens. This NMA will address Chinese herbal injections for SP and its findings may help to provide more sights for selection of SP treatment. Evidence drawn from an NMA is limited and should be interpreted with caution. We only included studies in Chinese and English languages, which may increase the publication bias.
format Online
Article
Text
id pubmed-9126378
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-91263782022-05-24 Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials Xiao, Lu Niu, Liqing Zhang, Xuemin Liu, Xuezheng Liu, Xinqiao Sun, Chongxiang Yang, Xiaokun PLoS One Study Protocol BACKGROUND: Severe pneumonia (SP) has a high mortality and is responsible for significant healthcare cost. Chinese herbal injections (CHIs) have been widely used in China as a novel and promising treatment option for SP. Therefore, this study will assess and rank the effectiveness of CHIs to provide more sights for the selection of SP treatment. METHOD: Seven databases will be searched, including PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Database, and the Chinese Scientific Journal Database (VIP) from their inception up to October, 2021. The literatures screening, data extraction and the quality assessment of included studies will be conducted independently by two reviewers. Then Bayesian network meta-analysis (NMA) will be performed by WinBUGS 14.0 and STATA 14.0 software. Surface under the cumulative ranking curve (SUCRA) probability values will be applied to rank the examined treatments. The risk of bias of each included study will be evaluated using the Revised Cochrane risk-of-bias tool for randomized trials (ROB 2). Publication bias will be reflected by a funnel plot. RESULTS: The results of this NMA will be disseminated through a peer-reviewed journal publication. CONCLUSION: Our study findings maybe reveal which CHI or CHIs will be better in the treatment of SP and provide more therapy strategies for clinical practitioners and patients. PROSPERO REGISTRATION NUMBER: CRD42021244587. STRENGTHS AND LIMITATIONS OF THIS STUDY: Bayesian network meta-analysis (NMA) can integrate direct evidence with indirect evidence of severe pneumonia treated by Chinese herbal injections to generate a clinically useful ranking of these regimens. This NMA will address Chinese herbal injections for SP and its findings may help to provide more sights for selection of SP treatment. Evidence drawn from an NMA is limited and should be interpreted with caution. We only included studies in Chinese and English languages, which may increase the publication bias. Public Library of Science 2022-05-23 /pmc/articles/PMC9126378/ /pubmed/35604894 http://dx.doi.org/10.1371/journal.pone.0262776 Text en © 2022 Xiao et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
Xiao, Lu
Niu, Liqing
Zhang, Xuemin
Liu, Xuezheng
Liu, Xinqiao
Sun, Chongxiang
Yang, Xiaokun
Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials
title Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials
title_full Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials
title_fullStr Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials
title_full_unstemmed Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials
title_short Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials
title_sort comparative efficacy of chinese herbal injections for treating severe pneumonia: a protocol for systematic review and bayesian network meta-analysis of randomized controlled trials
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126378/
https://www.ncbi.nlm.nih.gov/pubmed/35604894
http://dx.doi.org/10.1371/journal.pone.0262776
work_keys_str_mv AT xiaolu comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT niuliqing comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT zhangxuemin comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT liuxuezheng comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT liuxinqiao comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT sunchongxiang comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials
AT yangxiaokun comparativeefficacyofchineseherbalinjectionsfortreatingseverepneumoniaaprotocolforsystematicreviewandbayesiannetworkmetaanalysisofrandomizedcontrolledtrials